The ASBMB’s Public Affairs Department encourages all readers of the Policy Blotter to alert the office about interesting and relevant articles. Please send tips to email@example.com.
What’s new in Blotter news?
The ASBMB’s policy analyst, André Porter, recaps this week’s U.S. House Science, Space and Technology subcommittee hearing on how much of overhead costs for research should funded by federal agencies.
The ASBMB’s director of public affairs, Benjamin Corb, provides an official statement rejecting President Donald Trump’s proposed FY18 budget.
Porter discusses the National Institutes of Health’s proposed Grant Research Index and provides a letter that ASBMB sent to NIH leadership outlining concerns and providing recommendations.
The biggest news coming out of D.C. this week was the release of Trump’s FY18 budget proposal. As expected, Trump proposed massive cuts to nondefense programs, including devastating reductions for the nation’s health and scientific agencies. In his proposal, Trump calls for a $5.8 billion reduction at the NIH, including a $1 billion cut to the National Cancer Institute, an $838 million cut to the National Institute of Allergy and Infectious Disease and a $575 million cut to the National Heart, Lung, and Blood Institute. Politics aside, members of the scientific and medical communities have banded together and voiced their displeasure for this proposal, arguing that such massive cuts would be devastating to America’s standing as a global leader in innovation. ASBMB’s Corb said: “Overall, the president’s budget would bring total federal investments in scientific research spending to a 40-year low.”
How Trump’s budget would weaken public health (The Atlantic)
In response to Trump’s push to cripple scientific research, lawmakers in D.C., Republicans and Democrats alike, were quick to denounce the president’s proposal and refer to it as “dead on arrival.” U.S. Rep. Tom Cole, R-Okla., is chairman for the House Appropriations Subcommittee on labor, health and human services, education and related agencies, which controls the NIH’s budget. Historically, Cole has been a strong champion for the NIH, spearheading past efforts resulting in NIH budget increases. Cole described Trump’s FY18 budget plan as “penny wise and pound foolish.”